Novartis Q3 core net income rises to $3.47 bln

Credit: REUTERS/CHARLES PLATIAU

Swiss drugmaker Novartis said on Tuesday that third-quarter core net income was $3.47 billion, up from $3.21 billion a year ago.

Adds details about targets

ZURICH, Oct 27 (Reuters) - Swiss drugmaker Novartis NOVN.Ssaid on Tuesday that third-quarter core net income was $3.47 billion, up from $3.21 billion a year ago.

Analysts polled by Refinitiv had, on average, forecast $3.2 billion.

For 2020, the Basel-based company broadened its core operating income growth forecast to low double-digit to mid-teen percentage rate growth, from a low double-digit range previously, while net sales are expected to grow in the mid-single-digit percentage range.

(Reporting by John Miller; editing by Brenna Hughes Neghaiwi)

((J.Miller@thomsonreuters.com; +41 58 306 7734; Reuters Messaging: j.miller.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NOVN

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More